IHS Chemical Week
HomeWhite PapersStatistics/DataCalendarSearch


Fine and Custom Chemicals

10:59 AM MDT | March 21, 2008 | Alex Scott in Zurich

Pharmaceutical manufacturers often produce drugs using hazardous materials and high temperatures, and their manufacturing processes frequently generate significantly more by-product than the final drug product itself. Sustainable manufacturing historically has not been a priority for the sector, analysts say. This is changing, however, due to: rising raw material prices; increasing pressure to reduce costs; and growing pressure from environmental groups and regulators on pharma and chemical companies to adopt sustainable manufacturing practices. Western pharma...

Already an IHS Chemical Week member?
Login here


Forgot your user ID or password?
Click here to have it sent to you.


Free Sustainability Offer Click here for 6 months access to the lates news, data and statistics on sustainability.  PLUS all the news and analysis from the Chemical Week editorial team updated everyday on IHS Chemical Week

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa